Clinical Efficacy of Bedaquiline-Containing Short-Course Regimens in Multi-Drug-Resistant Tuberculosis: Experience from Central Rajasthan
UAPM Journal of Respiratory Diseases and Allied Sciences · 15.07.2026 · 3 (02) · 15-18
DOI: 10.70192/v3.i2.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift UAPM Journal of Respiratory Diseases and Allied Sciences, online erschienen am 15.07.2026. Verfasst von Pallavi Pillai und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Multidrug-resistant tuberculosis (MDR-TB) continues to pose a critical threat to global public health, with India bearing nearly one-fourth of the world’s total burden. The emergence of bedaquiline-containing regimens has significantly improved treatment outcomes in MDR-TB due to enhanced bactericidal activity and shorter treatment duration.
Objectives
To evaluate the efficacy and treatment outcomes of a bedaquiline-containing short-course regimen in multidrug-resistant tuberculosis (MDR-TB) patients at a tertiary care center in Central Rajasthan.
Methods
This observational study was conducted among 100 MDR-TB patients registered at our center. Patients underwent detailed pre-treatment clinical, radiological, biochemical, and microbiological evaluation. Demographic details, co-morbidities, socioeconomic status, addiction history, and previous anti-tuberculosis treatment (ATT) exposure were recorded. We initiated patients on a short-course bedaquiline regimen and followed them according to the Programmatic Management of Drug-Resistant Tuberculosis (PMDT) guidelines. Treatment outcomes were categorized as cured, treatment completed, treatment failure, loss to follow-up, regimen change, or death. Sputum conversion, clinical improvement, radiological response, and adverse drug reactions were also assessed.
Results
Most patients (64%) were aged 21 to 50, the economically productive years, with a mean age of 34.97 ± 12.46 years. Males constituted 71% of the study population. Most patients were underweight (70%), and pulmonary tuberculosis was present in 92% of cases. Previous history of ATT was observed in 42% of patients. Smear conversion was achieved in 71% of patients, while radiological regression was noted in 62%. Complete clinical improvement occurred in 53% of cases. Final treatment analysis indicated a cure rate of 67%, with 11% died, 10% were lost to follow-up, 8% required regimen modification, and 4% experienced treatment failure. Adverse drug reactions were observed in 37% of patients, most commonly gastrointestinal symptoms and dermatological manifestations.
Conclusion
The bedaquiline-containing short course regimen demonstrated favorable treatment outcomes with acceptable safety among MDR-TB patients. Shorter treatment duration, improved cure rates, and manageable adverse effects support the wider implementation of bedaquiline-based regimens in the programmatic management of MDR-TB in India.
Zitieren
APA
Pillai, P., Kuldeep, R., Gupta, N., Dixit, R., Meghwanshi, R., & Lalremmawii, E. (2026). Clinical Efficacy of Bedaquiline-Containing Short-Course Regimens in Multi-Drug-Resistant Tuberculosis: Experience from Central Rajasthan. UAPM Journal of Respiratory Diseases and Allied Sciences, 3(02), 15-18. https://doi.org/10.70192/v3.i2.03
Vancouver
Pillai P, Kuldeep R, Gupta N, Dixit R, Meghwanshi R, Lalremmawii E. Clinical Efficacy of Bedaquiline-Containing Short-Course Regimens in Multi-Drug-Resistant Tuberculosis: Experience from Central Rajasthan. UAPM Journal of Respiratory Diseases and Allied Sciences. 2026;3(02):15-18. doi:10.70192/v3.i2.03
BibTeX
@article{Pillai2026,
author = {Pillai, Pallavi and Kuldeep, Rajveer and Gupta, Neeraj and Dixit, Ramakant and Meghwanshi, Ranjeet and Lalremmawii, Elizabeth},
title = {Clinical Efficacy of Bedaquiline-Containing Short-Course Regimens in Multi-Drug-Resistant Tuberculosis: Experience from Central Rajasthan},
journal = {UAPM Journal of Respiratory Diseases and Allied Sciences},
year = {2026},
volume = {3},
number = {02},
pages = {15--18},
doi = {10.70192/v3.i2.03}
}
EUVIMED